Related Experiment Video
Updated: Jun 27, 2026

Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion
Published on: April 5, 2016
Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function
Jennifer C Fleming1, Feng Bao, Yuhua Chen
1Spinal Cord Injury Laboratory, BioTherapeutics Research Group, Robarts Research Institute, The University of Western Ontario, London, Ontario, Canada N6A 5K8.
Blocking alpha4beta1 integrin with an antibody reduced inflammation and oxidative stress after spinal cord injury (SCI) in rats. This treatment improved motor function, reduced autonomic dysreflexia, and decreased hypersensitivity, indicating neuroprotection.
Area of Science:
- Neuroscience
- Immunology
- Regenerative Medicine
Background:
- Spinal cord injury (SCI) leads to secondary tissue damage driven by inflammatory cells like neutrophils and macrophages.
- The integrin alpha4beta1 on leukocytes is crucial for their migration and activation, contributing to post-injury inflammation.
- Targeting alpha4beta1 offers a potential neuroprotective strategy to mitigate SCI-induced damage.
Purpose of the Study:
- To investigate the neuroprotective effects of blocking the alpha4beta1 integrin in a rat model of spinal cord injury.
- To assess the impact of anti-alpha4beta1 treatment on inflammatory cell infiltration, oxidative stress, and functional recovery after SCI.
Main Methods:
- Rats received intravenous administration of a blocking monoclonal antibody against the alpha4 subunit of alpha4beta1 at 2 and 24 hours post-SCI.
- Inflammatory cell influx (neutrophils, monocyte/macrophages) and oxidative markers (myeloperoxidase, inducible nitric oxide, free radicals, lipid peroxidation) were quantified.
- Locomotor function, autonomic dysreflexia, mechanical allodynia, and histological outcomes (spared white matter, serotonergic axons) were evaluated at various time points post-injury.
Main Results:
- Anti-alpha4beta1 treatment significantly reduced neutrophil (47-61%) and monocyte/macrophage (53%) influx at 3-7 days post-SCI.
- A significant decrease in oxidative stress markers, including myeloperoxidase (38%), inducible nitric oxide (44%), and lipid peroxidation (42%), was observed.
- Treated rats showed improved motor function (up to 2 points), reduced blood pressure responses during autonomic dysreflexia (43%), and decreased mechanical allodynia (40-54%).
Conclusions:
- Blocking alpha4beta1 integrin is a promising neuroprotective strategy for spinal cord injury.
- This treatment reduces post-injury inflammation and oxidative damage, leading to significant improvements in neurological function and a reduction in SCI-related complications.
- The findings support the potential of anti-integrin therapies for managing SCI.
Related Concept Videos
Spinal Cord Injury ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology
Intracellular Signaling Affects Focal Adhesions
Some...
